Analytics, not advice. Rankings and scores describe past performance and are not recommendations.
21slipping
Latest NAV
₹477.0292
as of 07 Aug 2026
AUM
—
Expense ratio
—
Inception
14 May 2026
FundScore
21/100slipping
Rank #242 of 322 · top 79%
A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.
Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
6.32%
3M
1.99%
6M
-5.38%
1Y
-1.69%
3Y CAGR
3.44%
5Y CAGR
2.80%
Since incep.
9.65%
NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.
Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.
Pro
Market-cap distribution
Large / mid / small / micro-cap split of this fund's equity holdings, from its latest look-through portfolio. Shown as a share of classified equity.
Large cap100.0%
Stock holdings
Latest portfolio disclosure for this scheme. Snapshot as of 31 May 2026.
Infosys Limited
equity
17.30%
Tata Consultancy Services Limited
equity
9.81%
Hindustan Unilever Limited
equity
8.13%
Sun Pharmaceutical Industries Limited
equity
8.10%
Hindalco Industries Limited
equity
6.93%
UltraTech Cement Limited
equity
5.78%
HCL Technologies Limited
equity
5.31%
Asian Paints Limited
equity
5.14%
Oil & Natural Gas Corporation Limited
equity
4.39%
Nestle India Limited
equity
4.33%
Tech Mahindra Limited
equity
4.01%
Trent Limited
equity
3.99%
Tata Motors Passenger Vehicles Limited
equity
3.50%
Dr. Reddy's Laboratories Limited
equity
3.38%
Cipla Limited
equity
3.35%
Tata Consumer Products Limited
equity
3.26%
Max Healthcare Institute Limited
equity
3.05%